{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T23:18:44Z","timestamp":1768087124272,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alexander disease (AxD) is classified into AxD type I (infantile) and AxD type II (juvenile and adult form). We aimed to determine the potential genetic cause(s) contributing to the AxD type II manifestations in a 9-year-old male who presented area postrema-like syndrome and his vomiting and weight loss improved after taking prednisolone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A normal cognitive 9-year-old boy with persistent nausea, vomiting, and a significant weight loss at the age of 6 years was noticed. He also experienced an episode of status epilepticus with generalized atonic seizures. He showed non-febrile infrequent multifocal motor seizures at the age of 40 days which were treated with phenobarbital. He exhibited normal physical growth and neurologic developmental milestones by the age of six. Occasionally vomiting unrelated to feeding was reported. Upon examination at 9 years, a weak gag reflex, prominent drooling, exaggerated knee-deep tendon reflexes (3+), and nasal tone speech was detected. All gastroenterological, biochemical, and metabolic assessments were normal. Brain magnetic resonance imaging (MRI) revealed bifrontal confluent deep and periventricular white matter signal changes, fine symmetric frontal white matter and bilateral caudate nucleus involvements with garland changes, and a hyperintense tumefactive-like lesion in the brain stem around the floor of the fourth ventricle and area postrema with contrast uptake in post-contrast T1-W images. Latter MRI at the age of 8 years showed enlarged area postrema lesion and bilateral middle cerebellar peduncles and dentate nuclei involvements. Due to clinical and genetic heterogeneities, whole-exome sequencing was performed and the candidate variant was confirmed by Sanger sequencing. A <jats:italic>de novo<\/jats:italic> heterozygous mutation, NM_001242376.1:c.262\u00a0C\u2009&gt;\u2009T;R88C in exon 1 of the <jats:italic>GFAP<\/jats:italic> (OMIM: 137,780) was verified. Because of persistent vomiting and weight loss of 6.0\u00a0kg, prednisolone was prescribed which brought about ceasing vomiting and led to weight gaining of 3.0\u00a0kg over the next 3 months after treatment. Occasional attempts to discontinue prednisolone had been resulting in the reappearance of vomiting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study broadens the spectrum of symptomatic treatment in leukodystrophies and also shows that R88C mutation may lead to a broad range of phenotypes in AxD type II patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03468-y","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T10:03:00Z","timestamp":1657706580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Symptomatic care of late-onset Alexander disease presenting with area postrema-like syndrome with prednisolone; a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Safoura","family":"Zardadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Razmara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Rasoulinezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meisam","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-7903","authenticated-orcid":false,"given":"Masoud","family":"Garshasbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Reza","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"13","key":"3468_CR1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1212\/WNL.0b013e3182309f72","volume":"77","author":"M Prust","year":"2011","unstructured":"Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 2011;77(13):1287\u201394. https:\/\/doi.org\/10.1212\/WNL.0b013e3182309f72.","journal-title":"Neurology"},{"issue":"4","key":"3468_CR2","first-page":"481","volume":"23","author":"M-R Ashrafi","year":"2013","unstructured":"Ashrafi M-R, Tavasoli A, Aryani O, Alizadeh H, Houshmand M. Alexander disease: report of two unrelated infantile form cases, identified by GFAP mutation analysis and review of literature; the first report from Iran. Iran J Pediatr. 2013;23(4):481.","journal-title":"Iran J Pediatr"},{"issue":"4","key":"3468_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.nurt.2010.05.013","volume":"7","author":"A Messing","year":"2010","unstructured":"Messing A, Daniels CML, Hagemann TL. Strategies for treatment in Alexander disease. Neurotherapeutics. 2010;7(4):507\u201315. https:\/\/doi.org\/10.1016\/j.nurt.2010.05.013.","journal-title":"Neurotherapeutics"},{"issue":"11","key":"3468_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1212\/wnl.0000000000012462","volume":"97","author":"F Renaldo","year":"2021","unstructured":"Renaldo F, Chalard F, Valence S, Burglen L, Rodriguez D. Area postrema syndrome as the initial presentation of Alexander disease. Neurology. 2021;97(11):548\u20139. https:\/\/doi.org\/10.1212\/wnl.0000000000012462.","journal-title":"Neurology"},{"issue":"1","key":"3468_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/14737175.2020.1699060","volume":"20","author":"MR Ashrafi","year":"2020","unstructured":"Ashrafi MR, Amanat M, Garshasbi M, Kameli R, Nilipour Y, Heidari M, et al. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies. Expert Rev Neurother. 2020;20(1):65\u201384. https:\/\/doi.org\/10.1080\/14737175.2020.1699060.","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"3468_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/WNL.0000000000001157","volume":"84","author":"NI Wolf","year":"2015","unstructured":"Wolf NI, Toro C, Kister I, Abd Latif K, Leventer R, Pizzino A, et al. DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder. Neurology. 2015;84(3):226\u201330. https:\/\/doi.org\/10.1212\/WNL.0000000000001157.","journal-title":"Neurology"},{"issue":"5","key":"3468_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1086\/323799","volume":"69","author":"D Rodriguez","year":"2001","unstructured":"Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N\u2019guyen S, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet. 2001;69(5):1134\u201340. https:\/\/doi.org\/10.1086\/323799.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"3468_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/jhg.2012.152","volume":"58","author":"L Zang","year":"2013","unstructured":"Zang L, Wang J, Jiang Y, Gu Q, Gao Z, Yang Y, et al. Follow-up study of 22 Chinese children with Alexander disease and analysis of parental origin of de novo GFAP mutations. J Hum Genet. 2013;58(4):183\u20138. https:\/\/doi.org\/10.1038\/jhg.2012.152.","journal-title":"J Hum Genet"},{"issue":"2","key":"3468_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/0883073807308691","volume":"23","author":"Y Wu","year":"2008","unstructured":"Wu Y, Gu Q, Wang J, Yang Y, Wu X, Jiang Y. Clinical and genetic study in Chinese patients with Alexander disease. J Child Neurol. 2008;23(2):173\u20137. https:\/\/doi.org\/10.1177\/0883073807308691.","journal-title":"J Child Neurol"},{"issue":"12","key":"3468_CR10","doi-asserted-by":"publisher","first-page":"104096","DOI":"10.1016\/j.ejmg.2020.104096","volume":"63","author":"E Razmara","year":"2022","unstructured":"Razmara E, Azimi H, Tavasoli AR, Fallahi E, Sheida SV, Eidi M, et al. Novel neuroclinical findings of autosomal recessive primary microcephaly 15 in a consanguineous Iranian family. Eur J Med Genet. 2022;63(12):104096. https:\/\/doi.org\/10.1016\/j.ejmg.2020.104096.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"3468_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s10038-007-0124-7","volume":"52","author":"T Yoshida","year":"2007","unstructured":"Yoshida T, Tomozawa Y, Arisato T, Okamoto Y, Hirano H, Nakagawa M. The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells. J Hum Genet. 2007;52(4):362\u20139. https:\/\/doi.org\/10.1007\/s10038-007-0124-7.","journal-title":"J Hum Genet"},{"issue":"25","key":"3468_CR12","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1091\/mbc.e16-06-0362","volume":"27","author":"N-H Lin","year":"2016","unstructured":"Lin N-H, Huang Y-S, Opal P, Goldman RD, Messing A, Perng M-D. The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP. Mol Biol Cell. 2016;27(25):3980\u201390. https:\/\/doi.org\/10.1091\/mbc.e16-06-0362.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"3468_CR13","first-page":"541","volume":"22","author":"MS van der Knaap","year":"2001","unstructured":"van der Knaap MS, Naidu S, Breiter SN, Blaser S, Stroink H, Springer S, et al. Alexander Disease: Diagnosis with MR Imaging. Am J Neuroradiol. 2001;22(3):541\u201352.","journal-title":"Am J Neuroradiol"},{"key":"3468_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121\u201330. https:\/\/doi.org\/10.1016\/j.ceb.2015.02.004.","journal-title":"Curr Opin Cell Biol"},{"issue":"20","key":"3468_CR15","first-page":"4368","volume":"127","author":"R Kanski","year":"2014","unstructured":"Kanski R, Sneeboer MA, van Bodegraven EJ, Sluijs JA, Kropff W, Vermunt MW, et al. Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. J Cell Sci. 2014;127(20):4368\u201380.","journal-title":"J Cell Sci"},{"issue":"2","key":"3468_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2478\/bjmg-2019-0017","volume":"22","author":"J Paprocka","year":"2019","unstructured":"Paprocka J, Rzepka-Migut B, Rzepka N, Jezela-Stanek A, Morava E. Infantile Alexander disease with late onset infantile spasms and hypsarrhythmia. Balkan J Med genetics: BJMG. 2019;22(2):77. https:\/\/doi.org\/10.2478\/bjmg-2019-0017.","journal-title":"Balkan J Med genetics: BJMG"},{"issue":"6","key":"3468_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ejhg.2015.223","volume":"24","author":"M Van Poucke","year":"2016","unstructured":"Van Poucke M, Martl\u00e9 V, Van Brantegem L, Ducatelle R, Van Ham L, Bhatti S, et al. A canine orthologue of the human GFAP c. 716G > A (p. Arg239His) variant causes Alexander disease in a Labrador retriever. Eur J Hum Genet. 2016;24(6):852\u20136. https:\/\/doi.org\/10.1038\/ejhg.2015.223.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"3468_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ana.20406","volume":"57","author":"R Li","year":"2005","unstructured":"Li R, Johnson AB, Salomons G, Goldman JE, Naidu S, Quinlan R, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol. 2005;57(3):310\u201326. https:\/\/doi.org\/10.1002\/ana.20406.","journal-title":"Ann Neurol"},{"issue":"4","key":"3468_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-015-1469-1","volume":"130","author":"M Olabarria","year":"2015","unstructured":"Olabarria M, Putilina M, Riemer EC, Goldman JE. Astrocyte pathology in Alexander disease causes a marked inflammatory environment. Acta Neuropathol. 2015;130(4):469\u201386. https:\/\/doi.org\/10.1007\/s00401-015-1469-1.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3468_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.braindev.2019.07.010","volume":"42","author":"K Kora","year":"2020","unstructured":"Kora K, Kato T, Ide M, Tanaka T, Yoshida T. Inflammatory neuropathology of infantile Alexander disease: a case report. Brain Dev. 2020;42(1):64\u20138. https:\/\/doi.org\/10.1016\/j.braindev.2019.07.010.","journal-title":"Brain Dev"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03468-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T10:03:12Z","timestamp":1657706592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03468-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3468"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03468-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"20 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the local medical ethics committee of Tehran University of Medical Sciences, Tehran, Iran. The patient and his parents provided written, informed consent before the study commencement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was obtained in written form from legal guardians. The parents gave their written consent for their child\u2019s personal or clinical details along with any identifying images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}